1 Department of Medicine, Duke University School of Medicine and Duke Comprehensive Cancer Center, Durham, NC, and Department of Infectious Diseases, The University of Texas M. D. Anderson Cancer Center, Houston, TX.
Although improved supportive care has reduced mortality associated with febrile neutropenia, it continues to cause chemotherapy limitations, morbidity, mortality, and cost among patients with cancer.